Mednet Logo
HomeOphthalmologyQuestion

Is it safe to continue azathioprine in a patient with severe bilateral panuveitis (thought to be related to sarcoidosis) and benign ethnic neutropenia, given worsening neutropenia since starting the medication, or should an alternative immunosuppressive agent be considered?

2
3 Answers
Mednet Member
Mednet Member
Rheumatology · Virginia Commonwealth University Health System

In this case, I would consider stopping azathioprine and switching to an alternative medication, such as an anti-TNF agent. Although not a large drop in the PMN, azathioprine is known to cause leukopenia, and in a patient with known neutropenia, extra precaution should be taken. In the case of uveit...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Rheumatology · U.S. Department of Veterans Affairs

I think I would lean towards less neutropenic agents: DMARD MTX vs escalation to TNF. I could consider MMF or MFA but more leuko/neutropenia there. Even JAK would be safer if an appropriate CV candidate.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Rheumatology · University of California (San Francisco) School of Medicine

In a patient with presumed (as stated in the history provided; unclear how long the patient has been neutropenic) benign ethnic neutropenia who developed increasing neutropenia while on azathioprine for the treatment of bilateral panuveitis thought to be related to sarcoidosis, I would certainly con...

Register or Sign In to see full answer

Is it safe to continue azathioprine in a patient with severe bilateral panuveitis (thought to be related to sarcoidosis) and benign ethnic neutropenia, given worsening neutropenia since starting the medication, or should an alternative immunosuppressive agent be considered? | Mednet